Abiraterone Acetate; Niraparib Tosylate Patent Expiration
Abiraterone Acetate; Niraparib Tosylate is used for treating metastatic castration-resistant prostate cancer associated with a deleterious BRCA mutation. It was first introduced by Janssen Biotech Inc
Abiraterone Acetate; Niraparib Tosylate Patents
Given below is the list of patents protecting Abiraterone Acetate; Niraparib Tosylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Akeega | US11091459 | Niraparib compositions | Mar 27, 2038 | Janssen Biotech |
| Akeega | US11673877 | Niraparib compositions | Mar 27, 2038 | Janssen Biotech |
| Akeega | US11207311 | Method of treating prostate cancer | Jul 28, 2037 | Janssen Biotech |
| Akeega | US11986468 | Methods of treating prostate cancer | Jul 28, 2037 | Janssen Biotech |
| Akeega | US11986469 | Methods of treating prostate cancer | Jul 28, 2037 | Janssen Biotech |
| Akeega | US11992486 | Methods of treating prostate cancer | Jul 28, 2037 | Janssen Biotech |
| Akeega | US8859562 | Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer | Aug 04, 2031 | Janssen Biotech |
| Akeega | US8071623 | Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors | Mar 27, 2031 | Janssen Biotech |
| Akeega | US8436185 | Pharmaceutically acceptable salts of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide | Apr 24, 2029 | Janssen Biotech |
| Akeega | US8071579 | DNA damage repair inhibitors for the treatment of cancer | Aug 12, 2027 | Janssen Biotech |
| Akeega | US8143241 | DNA damage repair inhibitors for treatment of cancer | Aug 12, 2027 | Janssen Biotech |
Abiraterone Acetate; Niraparib Tosylate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List